Michael R Hayden, Director at Ionis Pharmaceuticals, bought IONS on Jul 31, 2026
Data as of Oct 16
- Traded
- Jul 31, 2026
- Disclosed
- Jul 31, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
IONS since disclosure
−17.1%
Similar stocks (XLV) since disclosure
+8.7%
XLV — its sector index fund
Change in closing price from Jul 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYMichael R Hayden DirectorIONS Ionis Pharmaceuticals Inc$801Kdisclosed Jul 31 · filed 1 day after the trade